세계의 흉터 치료 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Scar Treatment was estimated to be worth US$ 1123 million in 2024 and is forecast to a readjusted size of US$ 1815 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.

Skin is a seamless organ, like a fine cloth protecting valuable assets. Imagine a piece of silk. Just one small tear can make a big difference in how it looks. In addition, it is the same with skin. Any burn, injury, or other trauma, such as surgery, can cause a scar. Scarring is a natural part of the healing process after an injury. There are many methods to treat the scar, in this report; we only study the Topical Products, which include Creams, Gels, Scar Sheets and Other.

The scar treatment market is driven by the rising incidence of skin injuries due to surgeries, burns, trauma, and acne, especially among younger populations concerned with aesthetic appearance. Growing consumer awareness of skin care, increased access to dermatological procedures, and expanding medical tourism-particularly in Asia-Pacific and Latin America-are boosting demand for both topical treatments (like gels and silicone sheets) and procedural options (such as laser therapy and chemical peels). Technological innovation and the introduction of combination therapies are further supporting market growth. Despite growing demand, the market faces challenges such as high treatment costs for advanced procedures like laser therapy, which can limit access in cost-sensitive regions. Lack of standardized treatment protocols and variability in patient response to scar treatments can lead to inconsistent outcomes and reduce overall satisfaction. Moreover, the over-the-counter (OTC) market is flooded with unproven products, making it difficult for consumers to choose effective solutions and for premium brands to stand out. Regulatory approval processes and long product development cycles also add complexity for manufacturers.

This report aims to provide a comprehensive presentation of the global market for Scar Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Scar Treatment by region & country, by Type, and by Application.

The Scar Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Scar Treatment.

Market Segmentation

By Company

• Perrigo Company
• Smith & Nephew
• Alliance Pharma
• Rejuvaskin
• HRA Pharma
• Molnlycke Health Care
• Sonoma Pharmaceuticals
• Sientra
• Pacific World Corporation
• CCA Industries
• Velius
• Shanghai Shyndec Pharmaceutical
• Merz Pharma GmbH
• Bausch Health
• Menarini
• HansBioMed
• Huibo Medical

Segment by Type

• Creams
• Gels
• Scar Sheets
• Other

Segment by Application

• Hospitals
• Dermatology Clinics

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Scar Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Scar Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Scar Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Scar Treatment Product Introduction
• 1.2 Global Scar Treatment Market Size Forecast (2020-2031)
• 1.3 Scar Treatment Market Trends & Drivers
  • 1.3.1 Scar Treatment Industry Trends
  • 1.3.2 Scar Treatment Market Drivers & Opportunity
  • 1.3.3 Scar Treatment Market Challenges
  • 1.3.4 Scar Treatment Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Scar Treatment Players Revenue Ranking (2024)
• 2.2 Global Scar Treatment Revenue by Company (2020-2025)
• 2.3 Key Companies Scar Treatment Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Scar Treatment Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Scar Treatment
• 2.6 Scar Treatment Market Competitive Analysis
  • 2.6.1 Scar Treatment Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Scar Treatment Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Scar Treatment as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Creams
  • 3.1.2 Gels
  • 3.1.3 Scar Sheets
  • 3.1.4 Other
• 3.2 Global Scar Treatment Sales Value by Type
  • 3.2.1 Global Scar Treatment Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Scar Treatment Sales Value, by Type (2020-2031)
  • 3.2.3 Global Scar Treatment Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospitals
  • 4.1.2 Dermatology Clinics
• 4.2 Global Scar Treatment Sales Value by Application
  • 4.2.1 Global Scar Treatment Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Scar Treatment Sales Value, by Application (2020-2031)
  • 4.2.3 Global Scar Treatment Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Scar Treatment Sales Value by Region
  • 5.1.1 Global Scar Treatment Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Scar Treatment Sales Value by Region (2020-2025)
  • 5.1.3 Global Scar Treatment Sales Value by Region (2026-2031)
  • 5.1.4 Global Scar Treatment Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Scar Treatment Sales Value, 2020-2031
  • 5.2.2 North America Scar Treatment Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Scar Treatment Sales Value, 2020-2031
  • 5.3.2 Europe Scar Treatment Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Scar Treatment Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Scar Treatment Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Scar Treatment Sales Value, 2020-2031
  • 5.5.2 South America Scar Treatment Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Scar Treatment Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Scar Treatment Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Scar Treatment Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Scar Treatment Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Scar Treatment Sales Value, 2020-2031
  • 6.3.2 United States Scar Treatment Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Scar Treatment Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Scar Treatment Sales Value, 2020-2031
  • 6.4.2 Europe Scar Treatment Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Scar Treatment Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Scar Treatment Sales Value, 2020-2031
  • 6.5.2 China Scar Treatment Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Scar Treatment Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Scar Treatment Sales Value, 2020-2031
  • 6.6.2 Japan Scar Treatment Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Scar Treatment Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Scar Treatment Sales Value, 2020-2031
  • 6.7.2 South Korea Scar Treatment Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Scar Treatment Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Scar Treatment Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Scar Treatment Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Scar Treatment Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Scar Treatment Sales Value, 2020-2031
  • 6.9.2 India Scar Treatment Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Scar Treatment Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Perrigo Company
  • 7.1.1 Perrigo Company Profile
  • 7.1.2 Perrigo Company Main Business
  • 7.1.3 Perrigo Company Scar Treatment Products, Services and Solutions
  • 7.1.4 Perrigo Company Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.1.5 Perrigo Company Recent Developments
• 7.2 Smith & Nephew
  • 7.2.1 Smith & Nephew Profile
  • 7.2.2 Smith & Nephew Main Business
  • 7.2.3 Smith & Nephew Scar Treatment Products, Services and Solutions
  • 7.2.4 Smith & Nephew Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Smith & Nephew Recent Developments
• 7.3 Alliance Pharma
  • 7.3.1 Alliance Pharma Profile
  • 7.3.2 Alliance Pharma Main Business
  • 7.3.3 Alliance Pharma Scar Treatment Products, Services and Solutions
  • 7.3.4 Alliance Pharma Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.3.5 Alliance Pharma Recent Developments
• 7.4 Rejuvaskin
  • 7.4.1 Rejuvaskin Profile
  • 7.4.2 Rejuvaskin Main Business
  • 7.4.3 Rejuvaskin Scar Treatment Products, Services and Solutions
  • 7.4.4 Rejuvaskin Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Rejuvaskin Recent Developments
• 7.5 HRA Pharma
  • 7.5.1 HRA Pharma Profile
  • 7.5.2 HRA Pharma Main Business
  • 7.5.3 HRA Pharma Scar Treatment Products, Services and Solutions
  • 7.5.4 HRA Pharma Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.5.5 HRA Pharma Recent Developments
• 7.6 Molnlycke Health Care
  • 7.6.1 Molnlycke Health Care Profile
  • 7.6.2 Molnlycke Health Care Main Business
  • 7.6.3 Molnlycke Health Care Scar Treatment Products, Services and Solutions
  • 7.6.4 Molnlycke Health Care Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.6.5 Molnlycke Health Care Recent Developments
• 7.7 Sonoma Pharmaceuticals
  • 7.7.1 Sonoma Pharmaceuticals Profile
  • 7.7.2 Sonoma Pharmaceuticals Main Business
  • 7.7.3 Sonoma Pharmaceuticals Scar Treatment Products, Services and Solutions
  • 7.7.4 Sonoma Pharmaceuticals Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.7.5 Sonoma Pharmaceuticals Recent Developments
• 7.8 Sientra
  • 7.8.1 Sientra Profile
  • 7.8.2 Sientra Main Business
  • 7.8.3 Sientra Scar Treatment Products, Services and Solutions
  • 7.8.4 Sientra Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.8.5 Sientra Recent Developments
• 7.9 Pacific World Corporation
  • 7.9.1 Pacific World Corporation Profile
  • 7.9.2 Pacific World Corporation Main Business
  • 7.9.3 Pacific World Corporation Scar Treatment Products, Services and Solutions
  • 7.9.4 Pacific World Corporation Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.9.5 Pacific World Corporation Recent Developments
• 7.10 CCA Industries
  • 7.10.1 CCA Industries Profile
  • 7.10.2 CCA Industries Main Business
  • 7.10.3 CCA Industries Scar Treatment Products, Services and Solutions
  • 7.10.4 CCA Industries Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.10.5 CCA Industries Recent Developments
• 7.11 Velius
  • 7.11.1 Velius Profile
  • 7.11.2 Velius Main Business
  • 7.11.3 Velius Scar Treatment Products, Services and Solutions
  • 7.11.4 Velius Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.11.5 Velius Recent Developments
• 7.12 Shanghai Shyndec Pharmaceutical
  • 7.12.1 Shanghai Shyndec Pharmaceutical Profile
  • 7.12.2 Shanghai Shyndec Pharmaceutical Main Business
  • 7.12.3 Shanghai Shyndec Pharmaceutical Scar Treatment Products, Services and Solutions
  • 7.12.4 Shanghai Shyndec Pharmaceutical Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.12.5 Shanghai Shyndec Pharmaceutical Recent Developments
• 7.13 Merz Pharma GmbH
  • 7.13.1 Merz Pharma GmbH Profile
  • 7.13.2 Merz Pharma GmbH Main Business
  • 7.13.3 Merz Pharma GmbH Scar Treatment Products, Services and Solutions
  • 7.13.4 Merz Pharma GmbH Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.13.5 Merz Pharma GmbH Recent Developments
• 7.14 Bausch Health
  • 7.14.1 Bausch Health Profile
  • 7.14.2 Bausch Health Main Business
  • 7.14.3 Bausch Health Scar Treatment Products, Services and Solutions
  • 7.14.4 Bausch Health Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.14.5 Bausch Health Recent Developments
• 7.15 Menarini
  • 7.15.1 Menarini Profile
  • 7.15.2 Menarini Main Business
  • 7.15.3 Menarini Scar Treatment Products, Services and Solutions
  • 7.15.4 Menarini Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.15.5 Menarini Recent Developments
• 7.16 HansBioMed
  • 7.16.1 HansBioMed Profile
  • 7.16.2 HansBioMed Main Business
  • 7.16.3 HansBioMed Scar Treatment Products, Services and Solutions
  • 7.16.4 HansBioMed Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.16.5 HansBioMed Recent Developments
• 7.17 Huibo Medical
  • 7.17.1 Huibo Medical Profile
  • 7.17.2 Huibo Medical Main Business
  • 7.17.3 Huibo Medical Scar Treatment Products, Services and Solutions
  • 7.17.4 Huibo Medical Scar Treatment Revenue (US$ Million) & (2020-2025)
  • 7.17.5 Huibo Medical Recent Developments

8 Industry Chain Analysis

• 8.1 Scar Treatment Industrial Chain
• 8.2 Scar Treatment Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Scar Treatment Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Scar Treatment Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer